{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:43:30Z","timestamp":1791333810281,"version":"4.3.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,29]],"date-time":"2016-09-29T00:00:00Z","timestamp":1475107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,9,29]],"date-time":"2016-09-29T00:00:00Z","timestamp":1475107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Japanese encephalitis virus (JEV) is a flavivirus that threatens more than half of the world\u2019s population. Vaccination can prevent the disease, but no specific antiviral drug is yet available for clinical therapy and the death rate caused by JEV can reach as high as 60%. The C-terminus of non-structural protein 3 (NS3) of flavivirus encodes helicase and has been identified as a potential drug target. In this study, high throughput molecular docking was employed to identify candidate JEV NS3 helicase inhibitors in a commercial library containing 250,000 compounds. Forty-one compounds were then tested for their ability to inhibit NS3 activity. Two compounds inhibited unwinding activity strongly but had no effect on the ATPase activity of the protein. Western blots, IFA and plaque reduction assays demonstrated that both compounds inhibited the virus in cell culture. The EC50s of the two compounds were 25.67 and 23.50\u2009\u03bcM, respectively. Using simulated docking, the two compounds were shown to bind and block the NS3 RNA unwinding channel, consistent with the results of the enzyme inhibition tests. The atoms participating in intramolecular interaction were identified to facilitate future compound optimization.<\/jats:p>","DOI":"10.1038\/srep34550","type":"journal-article","created":{"date-parts":[[2016,9,29]],"date-time":"2016-09-29T09:41:50Z","timestamp":1475142110000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Structure-based discovery of two antiviral inhibitors targeting the NS3 helicase of Japanese encephalitis virus"],"prefix":"10.1038","volume":"6","author":[{"given":"Jin\u2019e","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dexin","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengbo","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiqing","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanchun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,29]]},"reference":[{"key":"BFsrep34550_CR1","first-page":"201","volume":"16","author":"JS Mackenzie","year":"2007","unstructured":"Mackenzie, J. S., Williams, D. T. & Smith, D. W. Japanese Encephalitis Virus: The Geographic Distribution, Incidence and Spread of a Virus with a Propensity to Emerge in New Areas. Persp Med V 16, 201\u2013268 (2007).","journal-title":"Persp Med V"},{"key":"BFsrep34550_CR2","first-page":"49","volume":"267","author":"JS Mackenzie","year":"2002","unstructured":"Mackenzie, J. S., Johansen, C. A., Ritchie, S. A., van den Hurk, A. F. & Hall, R. A. Japanese encephalitis as an emerging virus: The emergence and spread of Japanese encephalitis virus in Australasia. Curr Top Microbiol 267, 49\u201373 (2002).","journal-title":"Curr Top Microbiol"},{"key":"BFsrep34550_CR3","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1111\/j.1348-0421.1994.tb01866.x","volume":"38","author":"A Igarashi","year":"1994","unstructured":"Igarashi, A. et al. Detection of West Nile and Japanese Encephalitis Viral Genome Sequences in Cerebrospinal-Fluid from Acute Encephalitis Cases in Karachi, Pakistan. Microbiol Immunol 38, 827\u2013830 (1994).","journal-title":"Microbiol Immunol"},{"key":"BFsrep34550_CR4","doi-asserted-by":"publisher","first-page":"585","DOI":"10.4269\/ajtmh.1993.48.585","volume":"48","author":"CJ Mitchell","year":"1993","unstructured":"Mitchell, C. J. et al. Japanese Encephalitis on Saipan - a Survey of Suspected Mosquito Vectors. Am J Trop Med Hyg 48, 585\u2013590 (1993).","journal-title":"Am J Trop Med Hyg"},{"key":"BFsrep34550_CR5","doi-asserted-by":"publisher","first-page":"e437","DOI":"10.1371\/journal.pntd.0000437","volume":"3","author":"D Ghosh","year":"2009","unstructured":"Ghosh, D. & Basu, A. Japanese encephalitis-a pathological and clinical perspective. PLoS neglected tropical diseases 3, e437 (2009).","journal-title":"PLoS neglected tropical diseases"},{"key":"BFsrep34550_CR6","doi-asserted-by":"publisher","first-page":"S98","DOI":"10.1038\/nm1144","volume":"10","author":"JS Mackenzie","year":"2004","unstructured":"Mackenzie, J. S., Gubler, D. J. & Petersen, L. R. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med 10, S98\u2013S109 (2004).","journal-title":"Nat Med"},{"key":"BFsrep34550_CR7","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1056\/NEJM198809083191004","volume":"319","author":"CH Hoke","year":"1988","unstructured":"Hoke, C. H. et al. Protection against Japanese Encephalitis by Inactivated Vaccines. New Engl J Med 319, 608\u2013614 (1988).","journal-title":"New Engl J Med"},{"key":"BFsrep34550_CR8","doi-asserted-by":"publisher","first-page":"214","DOI":"10.4269\/ajtmh.1988.39.214","volume":"39","author":"YX Yu","year":"1988","unstructured":"Yu, Y. X., Zhang, G. M., Guo, Y. P., Ao, J. & Li, H. M. Safety of a Live-Attenuated Japanese Encephalitis-Virus Vaccine (Sa14-14-2) for Children. Am J Trop Med Hyg 39, 214\u2013217 (1988).","journal-title":"Am J Trop Med Hyg"},{"key":"BFsrep34550_CR9","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.antiviral.2007.10.005","volume":"78","author":"EA Gould","year":"2008","unstructured":"Gould, E. A., Solomon, T. & Mackenzie, J. S. Does antiviral therapy have a role in the control of Japanese encephalitis? Antivir Res 78, 140\u2013149 (2008).","journal-title":"Antivir Res"},{"key":"BFsrep34550_CR10","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.antiviral.2015.03.014","volume":"118","author":"DH Luo","year":"2015","unstructured":"Luo, D. H., Vasudevan, S. G. & Lescar, J. The flavivirus NS2B-NS3 protease-helicase as a target for antiviral drug development. Antivir Res 118, 148\u2013158 (2015).","journal-title":"Antivir Res"},{"key":"BFsrep34550_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.antiviral.2015.03.007","volume":"118","author":"XP Xie","year":"2015","unstructured":"Xie, X. P., Zou, J., Wang, Q. Y. & Shi, P. Y. Targeting dengue virus NS4B protein for drug discovery. Antivir Res 118, 39\u201345 (2015).","journal-title":"Antivir Res"},{"key":"BFsrep34550_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.antiviral.2015.04.010","volume":"119","author":"SP Lim","year":"2015","unstructured":"Lim, S. P., Noble, C. G. & Shi, P. Y. The dengue virus NS5 protein as a target for drug discovery. Antivir Res 119, 57\u201367 (2015).","journal-title":"Antivir Res"},{"key":"BFsrep34550_CR13","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.antiviral.2013.09.013","volume":"100","author":"SP Lim","year":"2013","unstructured":"Lim, S. P. et al. Ten years of dengue drug discovery: Progress and prospects. Antivir Res 100, 500\u2013519 (2013).","journal-title":"Antivir Res"},{"key":"BFsrep34550_CR14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0014-5793(99)01705-6","volume":"465","author":"A Utama","year":"2000","unstructured":"Utama, A. et al. Identification and characterization of the RNA helicase activity of Japanese encephalitis virus NS3 protein. Febs Lett 465, 74\u201378 (2000).","journal-title":"Febs Lett"},{"key":"BFsrep34550_CR15","doi-asserted-by":"publisher","first-page":"9633","DOI":"10.1128\/JVI.75.20.9633-9643.2001","volume":"75","author":"AE Matusan","year":"2001","unstructured":"Matusan, A. E., Pryor, M. J., Davidson, A. D. & Wright, P. J. Mutagenesis of the Dengue virus type 2 NS3 protein within and outside helicase motifs: Effects on enzyme activity and virus replication. J Virol 75, 9633\u20139643 (2001).","journal-title":"J Virol"},{"key":"BFsrep34550_CR16","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nrd1853","volume":"4","author":"AD Kwong","year":"2005","unstructured":"Kwong, A. D., Rao, B. G. & Jeang, K. T. Viral and cellular RNA helicases as antiviral targets. Nat Rev Drug Discov 4, 845\u2013853 (2005).","journal-title":"Nat Rev Drug Discov"},{"key":"BFsrep34550_CR17","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.bbrc.2014.09.113","volume":"453","author":"C Basavannacharya","year":"2014","unstructured":"Basavannacharya, C. & Vasudevan, S. G. Suramin inhibits helicase activity of NS3 protein of dengue virus in a fluorescence-based high throughput assay format. Biochem Bioph Res Co 453, 539\u2013544 (2014).","journal-title":"Biochem Bioph Res Co"},{"key":"BFsrep34550_CR18","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1128\/AAC.02251-12","volume":"57","author":"CM Byrd","year":"2013","unstructured":"Byrd, C. M. et al. Novel Benzoxazole Inhibitor of Dengue Virus Replication That Targets the NS3 Helicase. Antimicrob Agents Ch 57, 1902\u20131912 (2013).","journal-title":"Antimicrob Agents Ch"},{"key":"BFsrep34550_CR19","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1093\/jac\/dks147","volume":"67","author":"E Mastrangelo","year":"2012","unstructured":"Mastrangelo, E. et al. Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug. J Antimicrob Chemoth 67, 1884\u20131894 (2012).","journal-title":"J Antimicrob Chemoth"},{"key":"BFsrep34550_CR20","doi-asserted-by":"publisher","first-page":"5714","DOI":"10.1021\/jm800503y","volume":"51","author":"MJ Stoermer","year":"2008","unstructured":"Stoermer, M. J. et al. Potent cationic inhibitors of West Nile virus NS2B\/NS3 protease with serum stability, cell permeability and antiviral activity. Journal of medicinal chemistry 51, 5714\u20135721 (2008).","journal-title":"Journal of medicinal chemistry"},{"key":"BFsrep34550_CR21","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.sbi.2010.03.011","volume":"20","author":"ME Fairman-Williams","year":"2010","unstructured":"Fairman-Williams, M. E., Guenther, U. P. & Jankowsky, E. SF1 and SF2 helicases: family matters. Curr Opin Struc Biol 20, 313\u2013324 (2010).","journal-title":"Curr Opin Struc Biol"},{"key":"BFsrep34550_CR22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev-biophys-050511-102243","volume":"41","author":"A Henn","year":"2012","unstructured":"Henn, A., Bradley, M. J. & De La Cruz, E. M. ATP Utilization and RNA Conformational Rearrangement by DEAD-Box Proteins. Annu Rev Biophys 41, 247\u2013267 (2012).","journal-title":"Annu Rev Biophys"},{"key":"BFsrep34550_CR23","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1146\/annurev.biophys.37.032807.125908","volume":"37","author":"AM Pyle","year":"2008","unstructured":"Pyle, A. M. Translocation and unwinding mechanisms of RNA and DNA helicases. Annual Review of Biophysics 37, 317\u2013336 (2008).","journal-title":"Annual Review of Biophysics"},{"key":"BFsrep34550_CR24","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/S1359-6446(02)02483-2","volume":"7","author":"PD Lyne","year":"2002","unstructured":"Lyne, P. D. Structure-based virtual screening: an overview. Drug Discov Today 7, 1047\u20131055 (2002).","journal-title":"Drug Discov Today"},{"key":"BFsrep34550_CR25","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S1367-5931(02)00339-3","volume":"6","author":"BK Shoichet","year":"2002","unstructured":"Shoichet, B. K., McGovern, S. L., Wei, B. Q. & Irwin, J. J. Lead discovery using molecular docking. Curr Opin Chem Biol 6, 439\u2013446 (2002).","journal-title":"Curr Opin Chem Biol"},{"key":"BFsrep34550_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jviromet.2013.08.005","volume":"194","author":"JE Fang","year":"2013","unstructured":"Fang, J. E. et al. Methods for detecting ATP hydrolysis and nucleic acid unwinding of Japanese encephalitis virus NS3 helicase. J Virol Methods 194, 33\u201338 (2013).","journal-title":"J Virol Methods"},{"key":"BFsrep34550_CR27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1089\/hyb.2011.0107","volume":"31","author":"Z Chen","year":"2012","unstructured":"Chen, Z. et al. Monoclonal Antibodies Against NS3 and NS5 Proteins of Japanese Encephalitis Virus. Hybridoma 31, 137\u2013141 (2012).","journal-title":"Hybridoma"},{"key":"BFsrep34550_CR28","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1099\/vir.0.19426-0","volume":"85","author":"KD Yang","year":"2004","unstructured":"Yang, K. D. et al. A model to study neurotropism and persistency of Japanese encephalitis virus infection in human neuroblastoma cells and leukocytes. The Journal of general virology 85, 635\u2013642 (2004).","journal-title":"The Journal of general virology"},{"issue":"11","key":"BFsrep34550_CR29","doi-asserted-by":"publisher","first-page":"e78425","DOI":"10.1371\/journal.pone.0078425","volume":"8","author":"Jin'e Fang","year":"2013","unstructured":"Fang, J. E. et al. Identification of Three Antiviral Inhibitors against Japanese Encephalitis Virus from Library of Pharmacologically Active Compounds 1280. Plos One 8 (2013).","journal-title":"PLoS ONE"},{"key":"BFsrep34550_CR30","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","volume":"51","author":"RA Laskowski","year":"2011","unstructured":"Laskowski, R. A. & Swindells, M. B. LigPlot+: Multiple Ligand-Protein Interaction Diagrams for Drug Discovery. J Chem Inf Model 51, 2778\u20132786 (2011).","journal-title":"J Chem Inf Model"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep34550","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep34550.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep34550.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T21:49:25Z","timestamp":1672868965000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep34550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,29]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,14]]}},"alternative-id":["BFsrep34550"],"URL":"https:\/\/doi.org\/10.1038\/srep34550","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,29]]},"assertion":[{"value":"28 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34550"}}